Feline Asthma: Managing Chronic Airway Disease for Welfare
Feline asthma causes episodic bronchospasm and chronic airway inflammation in affected cats, requiring long-term management to prevent life-threatening acute attacks.
Key Facts
- Feline asthma affects approximately 1-5% of cats worldwide
- Causes wheezing, coughing, open-mouth breathing, and in severe cases respiratory crisis
- Allergic bronchitis and asthma exist on a spectrum with different management implications
- Inhaled steroids via AeroKat spacer devices provide targeted welfare treatment with fewer systemic effects
- Emergency bronchodilator treatment is lifesaving during acute attacks
Welfare Considerations
Feline asthma creates dual welfare challenges: chronic low-level airway inflammation causing coughing and exercise intolerance, and the acute life-threatening attacks that can occur without warning. Cats experiencing acute severe asthma attacks crouch, extend their necks, and breathe with rapid open-mouth respiration — indicators of extreme respiratory distress. Emergency bronchodilator therapy and corticosteroids are lifesaving. Long-term management with inhaled steroids (via spacer devices) reduces airway inflammation and decreases attack frequency without the systemic steroid effects of oral medication. Allergen identification and reduction supports both chronic welfare and acute attack prevention.
What You Can Do
- Learn to recognize the difference between a cough and a respiratory crisis requiring emergency care
- Train your cat to accept inhaled medication using positive reinforcement and reward-based training
- Identify and reduce potential allergens in the environment
- Keep emergency medication available and know when to use it
- Schedule regular veterinary monitoring of airway disease control